brinzolamide + latanoprost

brinzolamide + latanoprost is a combination ophthalmic drug used for the treatment of glaucoma and ocular hypertension. Brinzolamide is a **carbonic anhydrase inhibitor** that lowers intraocular pressure by inhibiting the enzyme carbonic anhydrase in the ciliary body, decreasing aqueous humor production. Latanoprost is a **prostaglandin F2-alpha (FP) receptor agonist** that increases the uveoscleral outflow of aqueous humor. Their complementary mechanisms offer improved 24-hour intraocular pressure control compared to monotherapy, and studies have confirmed superior efficacy for controlling both diurnal and nocturnal eye pressure in patients[1][3][6].

Other names

Latanoprost 0.005% / Brinzolamide 1% fixed-dose combinationLatanoprost 50 μg/mL / Brinzolamide 10 mg/mLLatanoprost + Brinzolamide combination